Aurinia Pharmaceuticals (NASDAQ:AUPH) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Aurinia Pharmaceuticals (NASDAQ:AUPH – Free Report) (TSE:AUP) in a report released on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock. Several other equities analysts also recently commented on the company. Royal Bank of Canada upped their price objective on Aurinia Pharmaceuticals from $11.00 to […]

Related Keywords

United States ,Blackrock ,Nova Scotia ,Canada ,Davidrw Jayne , ,Insider Transactions At Aurinia Pharmaceuticals ,Armistice Capital ,Aurinia Pharmaceuticals Trading Down ,News Ratings For Aurinia Pharmaceuticals Daily ,Aurinia Pharmaceuticals Company Profile ,Otsuka Pharmaceutical Co Ltd ,Blackrock Inc ,Royal Bank ,Bellevue Group ,Aurinia Pharmaceuticals ,Aurinia Pharmaceuticals Inc ,Free Report ,Moderate Buy ,Pharmaceuticals Trading Down ,Get Free Report ,Street Corp ,Pharmaceuticals Inc ,Aurinia Pharmaceuticals Daily ,Nasdaq Auph ,Auph ,Medical ,Initiated Coverage ,Stocknews Com ,